KIK-AS clinical trial - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

India’s core industries maintained solid momentum in July 2026 as iron ore production surged 29.5%, cement output climbed 13.1% and electricity generation rose 9%, helping the Index of Core Industries expand 5.4% year on year. Representative image.

India Cements Capital (BSE: 511355) faces control shift in Rs 20cr deal

PepsiCo’s Rs 35cr Hyderabad lease deepens Kokapet’s GCC office momentum

BPCL (NSE: BPCL) clears Rs 5,000cr debt raise after Rs 3,962cr Q1 loss

How Paradip Port’s 18.5-metre draft could change eastern India bulk logistics

Read More

Pharma Industry News

KIK-AS clinical trial : Angelman syndrome drug candidate GTX-102 to be evaluated by GeneTx Biotherapeutics

GeneTx Biotherapeutics is set to start the KIK-AS clinical trial for evaluating GTX-102 for the treatment of Angelman…

bypharmanewsdaily

February 17, 2020

web analytics